Rheumatoid Arthritis Clinical Trials in Duncansville, Pennsylvania
4 studies are recruiting for rheumatoid arthritis in Duncansville, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
This study will assess the efficacy and safety of Afimkibart (also known as RO7790121) compared with placebo in participants with moderate to severe rheumatoid arthritis (RA) who have an inadequate response or intolerance to TNF and/or JAK inhibitors.
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Altoona Center For Clinical Research, Duncansville, Pennsylvania
- Locations
- 63 in total
- Run by
- Hoffmann-La Roche
-
Phase 1b/2 Study of IV Sarilumab in Adult With RA
This is a Phase 1/Phase 2 study with: * 5-arms design for Part A; * and a single arm for Part B. The purpose of this study is to measure PK parameters and safety with sarilumab intravenous (IV) with or without concomitant oral conventional synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) …
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Altoona Center for Clinical Research - Duncansville- Site Number : 8400007, Duncansville, Pennsylvania
- Locations
- 4 in total
- Run by
- Sanofi
-
RA-PRO PRAGMATIC TRIAL
The 2021 ACR RA treatment guideline, based on widely acknowledged low to moderate quality evidence, recommends switching to a non-tumor necrosis factor (TNFi) biologic (choose among existing medications, currently, rituximab, abatacept, tocilizumab, or sarilumab) or a targeted synthetic DMARD arm (…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Altoona Center for Clinical Research, Duncansville, Pennsylvania
- Locations
- 49 in total
- Run by
- University of Alabama at Birmingham
-
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will evaluate the efficacy and safety of targeted therapies through a series of substudies for the treatment of moderately to severely active Rheumatoid Arthritis (RA…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Altoona Center For Clinical Research /ID# 272479, Duncansville, Pennsylvania
- Locations
- 104 in total
- Run by
- AbbVie
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.